N-(3,4-dichlorophenyl)-2,4-5-(furan-2-ylmethylene)-2,4-dioxothiazolidin-3-yl)acetamide

ID: ALA4786111

Chembl Id: CHEMBL4786111

PubChem CID: 162668105

Max Phase: Preclinical

Molecular Formula: C16H10Cl2N2O4S

Molecular Weight: 397.24

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CN1C(=O)S/C(=C/c2ccco2)C1=O)Nc1ccc(Cl)c(Cl)c1

Standard InChI:  InChI=1S/C16H10Cl2N2O4S/c17-11-4-3-9(6-12(11)18)19-14(21)8-20-15(22)13(25-16(20)23)7-10-2-1-5-24-10/h1-7H,8H2,(H,19,21)/b13-7+

Standard InChI Key:  ICAVJFZAMZEZFA-NTUHNPAUSA-N

Alternative Forms

  1. Parent:

    ALA4786111

    ---

Associated Targets(Human)

SLC2A5 Tbio Solute carrier family 2, facilitated glucose transporter member 5 (25 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC2A1 Tchem Glucose transporter (14755 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
SLC2A4 Tchem Solute carrier family 2, facilitated glucose transporter member 4 (396 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CCRF-CEM (65223 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
K562 (73714 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KCL-22 (265 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
MDA-MB-231 (73002 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HS27 (243 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC8 Tclin Histone deacetylase 8 (4516 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HDAC4 Tclin Histone deacetylase 4 (2328 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 397.24Molecular Weight (Monoisotopic): 395.9738AlogP: 4.26#Rotatable Bonds: 4
Polar Surface Area: 79.62Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: 11.15CX Basic pKa: CX LogP: 3.25CX LogD: 3.25
Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.78Np Likeness Score: -2.52

References

1. Tilekar K,Upadhyay N,Hess JD,Macias LH,Mrowka P,Aguilera RJ,Meyer-Almes FJ,Iancu CV,Choe JY,Ramaa CS.  (2020)  Structure guided design and synthesis of furyl thiazolidinedione derivatives as inhibitors of GLUT 1 and GLUT 4, and evaluation of their anti-leukemic potential.,  202  [PMID:32634629] [10.1016/j.ejmech.2020.112603]

Source